Neuraptive Therapeutics
http://www.neuraptive.com/Neuraptive's lead product, AxoFuse, is a therapeutic for use during peripheral nerve surgery to improve outcomes for patients. AxoFuse has been shown to improve recovery of function and sensation in traumatic injury and has potential for the same across a wide array of reconstructive surgical protocols. The US market opportunity consists of ~1.4m eligible patients annually representing a >$5B global market.
Member count: 1-10
Total raised: $12.9M
Investors 2
| Date | Name | Website |
| - | Ben Frankl... | sep.benfra... |
| - | New Rhein ... | newrhein.c... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 20.12.2018 | Series A | $11.5M | - | finsmes.co... |
Mentions in press and media 4
| Date | Title | Description | Category | Author | Source |
| 25.07.2019 | Ben Frankl... | Avisi is a pre-clinical ... | - | - | sep.benfra... |
| 20.12.2018 | Neuraptive... | Neuraptive Therapeutics, Inc.,... | USA | - | finsmes.co... |
| 19.12.2018 | Neuraptive... | Neuraptive Therapeutics, Inc. ... | - | - | citybizlis... |
| 11.09.2017 | Tech Tools... | Share Share on Facebook Share ... | - | Angela Sha... | xconomy.co... |